167 related articles for article (PubMed ID: 23386708)
1. Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease.
de Boer HC; van Solingen C; Prins J; Duijs JM; Huisman MV; Rabelink TJ; van Zonneveld AJ
Eur Heart J; 2013 Nov; 34(44):3451-7. PubMed ID: 23386708
[TBL] [Abstract][Full Text] [Related]
2. Platelets, endothelium, and circulating microRNA-126 as a prognostic biomarker in cardiovascular diseases: per aspirin ad astra.
Cavarretta E; Chiariello GA; Condorelli G
Eur Heart J; 2013 Nov; 34(44):3400-2. PubMed ID: 23391580
[No Abstract] [Full Text] [Related]
3. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
[TBL] [Abstract][Full Text] [Related]
4. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
Nadar S; Blann AD; Lip GY
Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
[TBL] [Abstract][Full Text] [Related]
5. Vascular and platelet responses to aspirin in patients with coronary artery disease.
Blann AD; Kuzniatsova N; Lip GY
Eur J Clin Invest; 2013 Jan; 43(1):91-9. PubMed ID: 23198725
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
7. Soluble P-selectin as a marker of in vivo platelet activation.
Ferroni P; Martini F; Riondino S; La Farina F; Magnapera A; Ciatti F; Guadagni F
Clin Chim Acta; 2009 Jan; 399(1-2):88-91. PubMed ID: 18835553
[TBL] [Abstract][Full Text] [Related]
8. Hyperglycaemia suppresses microRNA expression in platelets to increase P2RY12 and SELP levels in type 2 diabetes mellitus.
Fejes Z; Póliska S; Czimmerer Z; Káplár M; Penyige A; Gál Szabó G; Beke Debreceni I; Kunapuli SP; Kappelmayer J; Nagy B
Thromb Haemost; 2017 Feb; 117(3):529-542. PubMed ID: 27975100
[TBL] [Abstract][Full Text] [Related]
9. Biological efficacy of twice daily aspirin in type 2 diabetic patients with coronary artery disease.
Dillinger JG; Drissa A; Sideris G; Bal dit Sollier C; Voicu S; Manzo Silberman S; Logeart D; Drouet L; Henry P
Am Heart J; 2012 Oct; 164(4):600-606.e1. PubMed ID: 23067920
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
11. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
Larsen SB; Grove EL; Kristensen SD; Hvas AM
Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions.
Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P
Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial.
Eikelboom JW; Hankey GJ; Thom J; Claxton A; Yi Q; Gilmore G; Staton J; Barden A; Norman PE
J Thromb Haemost; 2005 Dec; 3(12):2649-55. PubMed ID: 16359503
[TBL] [Abstract][Full Text] [Related]
14. Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications.
Spectre G; Arnetz L; Östenson CG; Brismar K; Li N; Hjemdahl P
Thromb Haemost; 2011 Sep; 106(3):491-9. PubMed ID: 21800009
[TBL] [Abstract][Full Text] [Related]
15. Markers of endothelial and platelet activation are associated with high on-aspirin platelet reactivity in patients with stable coronary artery disease.
Pettersen AÅ; Arnesen H; Opstad TB; Bratseth V; Seljeflot I
Thromb Res; 2012 Sep; 130(3):424-8. PubMed ID: 22795340
[TBL] [Abstract][Full Text] [Related]
16. Impairment of Wound Healing in Patients With Type 2 Diabetes Mellitus Influences Circulating MicroRNA Patterns via Inflammatory Cytokines.
Dangwal S; Stratmann B; Bang C; Lorenzen JM; Kumarswamy R; Fiedler J; Falk CS; Scholz CJ; Thum T; Tschoepe D
Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1480-8. PubMed ID: 25814674
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes.
Luo M; Li R; Deng X; Ren M; Chen N; Zeng M; Yan K; Xia J; Liu F; Ma W; Yang Y; Wan Q; Wu J
Acta Diabetol; 2015 Oct; 52(5):943-9. PubMed ID: 25820527
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation and aggregation profile in prolonged external ventricular support.
Houël R; Mazoyer E; Boval B; Kirsch M; Vermès E; Drouet L; Loisance DY
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):197-202. PubMed ID: 15282455
[TBL] [Abstract][Full Text] [Related]
19. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
[TBL] [Abstract][Full Text] [Related]
20. Circulating markers of endothelial dysfunction and platelet activation in patients with severe symptomatic cerebral small vessel disease.
Lavallée PC; Labreuche J; Faille D; Huisse MG; Nicaise-Roland P; Dehoux M; Gongora-Rivera F; Jaramillo A; Brenner D; Deplanque D; Klein IF; Touboul PJ; Vicaut E; Ajzenberg N;
Cerebrovasc Dis; 2013; 36(2):131-8. PubMed ID: 24029712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
